AI-generated summary
The authors propose a hypothesis, drawn from theoretical mechanisms rather than patient data, that light could reduce the lethality of COVID-19 through photobiomodulation. They describe effects on hemoglobin, porphyrin, ATP production and vitamin D, and suggest red and near-infrared wavelengths are most favorable. The abstract reports no clinical outcomes or experimental results to support the hypothesis.
- Who or what was studied
- COVID-19 patients (no sample described in the abstract)
- Wavelengths
- 640, 900 nm
- Limits stated in the abstract
- The abstract is a hypothesis and mechanistic proposal with no clinical or experimental data reported to test it.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 640 nm, 900 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Near-infrared, Adenosine triphosphate, Cytochrome c oxidase, Mitochondria, Ultraviolet, Photon. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.